Diabetes Mellitus and COVID-19: Review Article

Elamari, 2020, Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2, The Pan African medical journal, 37, 10.11604/pamj.2020.37.32.25192 Ceriello, 2020, Hyperglycemia and COVID-19: what was known and what is really new?, Diabetes Res Clin Pract, 167, 10.1016/j.diabres.2020.108383 Nassar, 2021, COVID-19 vaccine-induced myocarditis case report with literature review, 102205 Sterne, 2020, Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis, Jama, 324, 1330, 10.1001/jama.2020.17023 Alessi, 2020, Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes, Diabetol Metab Syndrome, 12, 80, 10.1186/s13098-020-00583-7 Di Dalmazi, 2020, Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study, BMJ open diabetes research & care, 8, 10.1136/bmjdrc-2020-001664 Biancalana, 2020, Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study, Acta Diabetol, 1 Lim, 2021, COVID-19 and diabetes mellitus: from pathophysiology to clinical management, Nat Rev Endocrinol, 17, 11, 10.1038/s41574-020-00435-4 Ceriello, 2020, Hyperglycemia and COVID-19: what was known and what is really new?, Diabetes Res Clin Pract, 167, 108383, 10.1016/j.diabres.2020.108383 Petrie, 2018, Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms, Can J Cardiol, 34, 575, 10.1016/j.cjca.2017.12.005 Giacco, 2010, Oxidative stress and diabetic complications, Circ Res, 107, 1058, 10.1161/CIRCRESAHA.110.223545 Berbudi, 2020, Type 2 diabetes and its impact on the immune system, Curr Diabetes Rev, 16, 442, 10.2174/1573399815666191024085838 Šestan, 2018, Virus-induced interferon-γ causes insulin resistance in skeletal muscle and derails glycemic control in obesity, Immunity, 49, 164, 10.1016/j.immuni.2018.05.005 Chen, 2020, The impact of COVID-19 on blood glucose: a systematic review and meta-analysis, Front Endocrinol, 11 Chatterjee, 2020, COVID-19: the endocrine opportunity in a pandemic, Minerva Endocrinol, 45, 204, 10.23736/S0391-1977.20.03216-2 Lippi, 2021, Response to: is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?, J Diabetes, 13, 179 Scheen, 2020, Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports, Diabetes Metab, 46, 265, 10.1016/j.diabet.2020.05.008 Wang, 2020, Impacts of type 2 diabetes on disease severity, therapeutic effect, and mortality of patients with COVID-19, J Clin Endocrinol Metab, 105, 10.1210/clinem/dgaa535 Moon, 2020, Independent impact of diabetes on the severity of coronavirus disease 2019 in 5,307 patients in South Korea: a nationwide cohort study, Diabetes & metabolism journal, 44, 737, 10.4093/dmj.2020.0141 Alvarado-Vasquez, 2020, Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19?, Med Hypotheses, 146 Nassar, 2021, The association between COVID-19 and type 1 diabetes mellitus: a systematic review, Diabetes Metab Syndr, 15, 447, 10.1016/j.dsx.2021.02.009 Ebekozien, 2020, Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U.S, Diabetes Care, 43, e83, 10.2337/dc20-1088 Barron, 2020, Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study, Lancet Diabetes Endocrinol, 8, 813, 10.1016/S2213-8587(20)30272-2 Holman, 2020, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, The Lancet Diabetes & Endocrinology, 8, 823, 10.1016/S2213-8587(20)30271-0 Rabbone, 2020, Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children?, Diabetes Care, 43, 2870, 10.2337/dc20-1321 Singh, 2021, Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: a Critical Appraisal of Literature, Diabetes Metab Syndr, 15, 159, 10.1016/j.dsx.2020.12.026 DeFronzo, 2016, Metformin-associated lactic acidosis: current perspectives on causes and risk, Metabolism, 65, 20, 10.1016/j.metabol.2015.10.014 Bornstein, 2020, Practical recommendations for the management of diabetes in patients with COVID-19, The Lancet Diabetes & Endocrinology, 8, 546, 10.1016/S2213-8587(20)30152-2 Chen, 2020, Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication, Diabetes Care, 43, 1399, 10.2337/dc20-0660 Sharma, 2020, Metformin in COVID-19: a possible role beyond diabetes, Diabetes Res Clin Pract, 164, 10.1016/j.diabres.2020.108183 Apicella, 2020, COVID-19 in people with diabetes: understanding the reasons for worse outcomes, The Lancet Diabetes & Endocrinology, 8, 782, 10.1016/S2213-8587(20)30238-2 Iacobellis, 2020, COVID-19 and diabetes: can DPP4 inhibition play a role?, Diabetes Res Clin Pract, 162, 10.1016/j.diabres.2020.108125 Bettge, 2017, Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials, Diabetes Obes Metabol, 19, 336, 10.1111/dom.12824 Bloodworth, 2018, Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology, J Allergy Clin Immunol, 142, 683, 10.1016/j.jaci.2018.01.053 Viby, 2013, Glucagon-like peptide-1 (GLP-1) reduces mortality and improves lung function in a model of experimental obstructive lung disease in female mice, Endocrinology, 154, 4503, 10.1210/en.2013-1666 Zhang, 2014, Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis, ScientificWorldJournal Ni, 2020, Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19, Crit Care, 24, 422, 10.1186/s13054-020-03120-0 Zhang, 2008, Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance, Arterioscler Thromb Vasc Biol, 28, 2312, 10.1161/ATVBAHA.108.175687 Mukherjee, 2020, Management of diabetes in patients with COVID-19, Lancet Diabetes Endocrinol, 8, 666, 10.1016/S2213-8587(20)30226-6 Garvey, 2018, Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes, Metabolism, 85, 32, 10.1016/j.metabol.2018.02.002 Kosiborod, 2021, Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: design and rationale for the DARE-19 study, Diabetes Obes Metabol, 23, 886, 10.1111/dom.14296 Dharam Lim, 2021, COVID-19 and diabetes mellitus: from pathophysiology to clinical management, Nat Rev Endocrinol, 17, 11, 10.1038/s41574-020-00435-4 Hansen, 2003, Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels, J Clin Endocrinol Metab, 88, 1082, 10.1210/jc.2002-021478 Longo, 2020, Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies, Cardiovasc Diabetol, 19, 115, 10.1186/s12933-020-01090-9 Organization, W.H. World Health Organization. WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int/. 2020 [cited 2020 12/12]; Available from: https://covid19.who.int/. Bode, 2020, Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States, J Diabetes Sci Technol, 14, 813, 10.1177/1932296820924469 Wang, 2020, Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study, Diabetologia, 63, 2102, 10.1007/s00125-020-05209-1 Zhu, 2020, Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes, Cell Metabol, 31, 1068, 10.1016/j.cmet.2020.04.021 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China, J Am Med Assoc, 323, 1061, 10.1001/jama.2020.1585 Lee, 2021, Effects of hyperglycaemia on complications of COVID-19: a meta-analysis of observational studies, Diabetes Obes Metabol, 23, 287, 10.1111/dom.14184 Palermo, 2020, Diabetic ketoacidosis in COVID-19: unique concerns and considerations, J Clin Endocrinol Metab, 105, 10.1210/clinem/dgaa360 Yang, 2010, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes, Acta Diabetol, 47, 193, 10.1007/s00592-009-0109-4 Li, 2020, COVID-19 infection may cause ketosis and ketoacidosis, Diabetes Obes Metabol, 22, 1935, 10.1111/dom.14057 Oriot, 2020, Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature, Acta Clin Belg, 1, 10.1080/17843286.2020.1780390 Alfishawy, 2021, New-onset type 1 diabetes mellitus with diabetic ketoacidosis and pancreatitis in a patient with COVID-19, Sci Afr, 13 Concepcion Zavaleta, 2020, Diabetic ketoacidosis during COVID-19 pandemic in a developing country, Diabetes Res Clin Pract, 168, 10.1016/j.diabres.2020.108391 Lawrence, 2021, Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID-19 pandemic, Diabet Med, 38, 10.1111/dme.14417 Goldman, 2020, High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care, Diabetes Res Clin Pract, 166, 10.1016/j.diabres.2020.108291 Chamorro-Pareja, 2020, Letter to the editor: unexpected high mortality in COVID-19 and diabetic ketoacidosis, Metab Clin Exp, 110, 10.1016/j.metabol.2020.154301 Korytkowski, 2020, A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic, J Clin Endocrinol Metab, 105, dgaa342, 10.1210/clinem/dgaa342 The Lancet, 2020, COVID-19 coagulopathy: an evolving story, Lancet Haematol, 7 Hwang, 2014, Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment, Diabetes Metab Res Rev, 30, 96, 10.1002/dmrr.2486 Nassar, 2021, Current systematic reviews and meta-analyses of COVID-19, World J Virol, 10, 182, 10.5501/wjv.v10.i4.182 Arabi, 2018, Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome, Am J Respir Crit Care Med, 197, 757, 10.1164/rccm.201706-1172OC Horby, 2020, Effect of hydroxychloroquine in hospitalized patients with covid-19, N Engl J Med, 383, 2030, 10.1056/NEJMoa2022926 Chen, 2020, Clinical characteristics and outcomes of type 2 diabetes patients infected with COVID-19: a retrospective study, Engineering, 6, 1170, 10.1016/j.eng.2020.05.017 Bhatt, 2021, High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections, Discoveries, 9, 10.15190/d.2021.5 Song, 2020, Fungal Co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China, Mycopathologia, 185, 599, 10.1007/s11046-020-00462-9 Heaney, 2021, Coccidioidomycosis and COVID-19 Co-infection, United States, 2020, Emerg Infect Dis, 27, 1266, 10.3201/eid2705.204661 Alosaimi, 2021, Influenza co-infection associated with severity and mortality in COVID-19 patients, Virol J, 18, 127, 10.1186/s12985-021-01594-0 Singh, 2021, Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India, Diabetes Metab Syndr, 15, 10.1016/j.dsx.2021.05.019 Ghosh, 2020, Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians, Diabetes Metab Syndr, 14, 273, 10.1016/j.dsx.2020.04.001 2020 Charles, 2000, Telemedicine can lower costs and improve access, Healthc Financ Manag, 54, 66 Tchero, 2019, Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials, Telemed J e Health, 25, 569, 10.1089/tmj.2018.0128